Pinz Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Pinz Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,200	Closed	-$171K	–	504
2021 Q2	$171K	Buy	+6,200	New	+$122K	0.05%	107
2020 Q3	–	Sell	-125,800	Closed	-$2.25M	–	203
2020 Q2	$2.25M	Buy	+125,800	New	+$1.9M	1.03%	38

Pinz Capital Management's TBIO Position: Q3 2021 in Review

Pinz Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 6,200 shares — an estimated $171K sold.

Pinz Capital Management first reported a position in TBIO in Q2 2020 and held it in 2 quarters. The position peaked at $2.25M in Q2 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Pinz Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Pinz Capital Management sold 6,200 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $171K.
Pinz Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
Pinz Capital Management's Translate Bio, Inc. Common Stock position peaked at $2.25M in Q2 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.